In a patient on lisinopril who is dehydrated and now has elevated blood urea nitrogen, serum creatinine, and serum potassium, is this acute kidney injury from the ACE inhibitor and volume depletion, and what immediate management steps should be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ACE Inhibitor-Induced Acute Kidney Injury with Volume Depletion

Yes, this is acute kidney injury (AKI) from the combination of lisinopril and volume depletion, and you must immediately discontinue the lisinopril, stop any diuretics, and restore intravascular volume. 1, 2

Diagnosis Confirmation

This patient meets KDIGO criteria for AKI Stage 1 based on the creatinine rise from 1.2 to what appears to be a higher value (exact current value not stated, but BUN elevated and potassium now concerning). 1 The clinical picture is classic for prerenal azotemia from ACE inhibitor use in a volume-depleted state:

  • Initial labs showed borderline hyperkalemia (5.0 mmol/L) with mild creatinine elevation (1.2 mg/dL) - these were warning signs that should have prompted lisinopril discontinuation 2
  • Suspected dehydration was present but lisinopril was continued - this was an error, as volume depletion is a critical contraindication to continuing ACE inhibitors 1, 2
  • Worsening BUN, creatinine, and potassium on repeat labs confirms progression of AKI 1, 3

The FDA label explicitly warns that lisinopril "can cause symptomatic hypotension, sometimes complicated by oliguria, progressive azotemia, acute renal failure or death" in patients with "severe volume and/or salt depletion of any etiology." 2

Immediate Management Steps

1. Discontinue Lisinopril Immediately

Stop lisinopril now - do not wait for further lab deterioration. 1, 2 The FDA label states to "consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on lisinopril." 2 In the setting of volume depletion with rising creatinine and hyperkalemia, this is mandatory, not optional. 1

2. Stop All Diuretics

Discontinue any diuretic therapy immediately if the patient is on diuretics. 1 The European Society of Cardiology guidelines state: "If using concomitant loop and thiazide diuretic stop thiazide diuretic" and "reduce dose/stop loop diuretics if possible" when renal impairment occurs. 1

3. Volume Repletion

Restore intravascular volume with intravenous normal saline (250-500 mL boluses) to correct the dehydration. 3 The European Heart Journal recommends this approach for patients with volume depletion causing elevated BUN. 3 Volume expansion is the primary treatment for ACE inhibitor-induced acute renal failure in the setting of volume depletion. 4

4. Review All Medications

Check for and immediately discontinue any NSAIDs, which are the most common culprit of worsening renal function in this setting. 1, 3 NSAIDs combined with ACE inhibitors and volume depletion create a "triple whammy" for the kidneys. 1, 4

5. Address Hyperkalemia

Monitor potassium closely and treat if ≥5.5 mmol/L. 3, 5 The patient's potassium of 5.0 mmol/L was already borderline, and with worsening renal function it will likely rise further. 2 Stop any potassium supplements or potassium-sparing diuretics. 1, 2

Monitoring Protocol

Recheck serum creatinine, BUN, and potassium within 1-2 weeks after discontinuing lisinopril and restoring volume. 1, 3, 5 The renal dysfunction should be reversible once the ACE inhibitor is stopped and volume status is corrected. 4, 6

Critical Pitfall You Made

The major error was continuing lisinopril when dehydration was suspected. 1, 2 The FDA label explicitly lists "severe volume and/or salt depletion of any etiology" as a condition requiring very close medical supervision or avoidance of lisinopril. 2 When you suspected dehydration with a potassium of 5.0 and creatinine of 1.2, the correct action was to:

  1. Stop the lisinopril immediately 1, 2
  2. Restore volume status 3
  3. Recheck labs in 1-2 weeks 1, 3
  4. Only restart lisinopril after volume repletion and normalization of renal function, if still indicated 1, 4

Expected Clinical Course

The renal dysfunction should reverse within days to weeks after stopping lisinopril and correcting volume depletion. 4, 6 Research shows that ACE inhibitor-induced acute renal failure in volume-depleted patients is "reversible after withdrawal of the drug." 4 The creatinine should return toward baseline once angiotensin II-mediated efferent arteriolar tone is restored and volume status is corrected. 4, 6

When to Restart ACE Inhibitor Therapy

Do not restart lisinopril until:

  • Volume status is fully restored 1, 3
  • Creatinine returns to within 0.3 mg/dL of baseline 1
  • Potassium is <5.0 mmol/L 3, 5
  • Patient has adequate oral intake and is not at risk for recurrent dehydration 1

If ACE inhibitor therapy is still indicated after recovery, restart at a lower dose with close monitoring of renal function and potassium within 1-2 weeks. 1, 5 Consider whether the patient truly needs an ACE inhibitor or if alternative antihypertensive therapy would be safer. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Elevated Blood Urea Nitrogen (BUN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of ARNI Dose with Rising Creatinine and Urea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

When should Angiotensin-Converting Enzyme (ACE) inhibitors or Angiotensin Receptor Blockers (ARBs) be stopped in patients with impaired renal function?
What is the best choice of antihypertensive medication for a patient with Acute Renal Failure (ARF) and hyperkalemia caused by Angiotensin-Converting Enzyme (ACE) inhibitors?
Can a patient on lisinopril (angiotensin-converting enzyme inhibitor) take Bactrim (trimethoprim/sulfamethoxazole)?
Can the elevated BUN (29 mg/dL) and serum creatinine (1.48 mg/dL) with hyperkalemia (potassium 5.7 mEq/L) be due to a hemolyzed blood specimen in a patient who recently discontinued lisinopril (40 mg)?
What to do with elevated Blood Urea Nitrogen (BUN) and creatinine levels after stopping lisinopril (angiotensin-converting enzyme inhibitor)?
What are the percentage risks of maternal and neonatal complications for a healthy woman undergoing a planned cesarean delivery?
Can the elevated BUN (29 mg/dL) and serum creatinine (1.48 mg/dL) with hyperkalemia (potassium 5.7 mEq/L) be due to a hemolyzed blood specimen in a patient who recently discontinued lisinopril (40 mg)?
In an elderly skilled‑nursing‑facility resident with a left‑basilar infiltrate, how can I distinguish a persistent infiltrate from a recurrent infiltrate?
How many days does it take for brivudine to be completely eliminated in a patient with normal renal and hepatic function?
What is the preferred antibiotic for a lower respiratory tract infection caused by Haemophilus influenzae, Streptococcus pneumoniae, and Klebsiella pneumoniae in children?
In an adult patient with baseline serum creatinine 1.2 mg/dL who had lisinopril (angiotensin‑converting enzyme inhibitor) stopped, diuretics held, NSAIDs discontinued, and received intravenous isotonic fluids, the creatinine has now risen to approximately 1.5 mg/dL; what further management steps should be taken?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.